U.S. markets close in 2 hours 24 minutes

VYNE Therapeutics Inc. (VYNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6950-0.0050 (-0.29%)
As of 1:35PM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/29/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
288.75M278.65M290.09M164.82M113.23M107.45M
Enterprise Value 3
247.96M214.99M243.26M87.88M22.74M-946.80k
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
9.627.0828.30N/AN/AN/A
Price/Book (mrq)
5.833.904.172.411.301.05
Enterprise Value/Revenue 3
14.8465.7720.8150.22N/AN/A
Enterprise Value/EBITDA 6
-0.99-9.18-1.46-2.25-1.040.05

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-54.79%
S&P500 52-Week Change 317.69%
52 Week High 34.0500
52 Week Low 31.0000
50-Day Moving Average 31.7444
200-Day Moving Average 31.7983

Share Statistics

Avg Vol (3 month) 31.8M
Avg Vol (10 day) 31.11M
Shares Outstanding 5167.88M
Float 141.43M
% Held by Insiders 14.00%
% Held by Institutions 149.54%
Shares Short (Nov 12, 2020) 49.7M
Short Ratio (Nov 12, 2020) 47.1
Short % of Float (Nov 12, 2020) 46.78%
Short % of Shares Outstanding (Nov 12, 2020) 45.78%
Shares Short (prior month Oct 14, 2020) 47.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-697.17%

Management Effectiveness

Return on Assets (ttm)-77.55%
Return on Equity (ttm)-524.45%

Income Statement

Revenue (ttm)16.84M
Revenue Per Share (ttm)0.24
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)443k
EBITDA -117.07M
Net Income Avi to Common (ttm)-270.21M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)76M
Total Cash Per Share (mrq)0.45
Total Debt (mrq)35.21M
Total Debt/Equity (mrq)71.10
Current Ratio (mrq)4.23
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-133.95M
Levered Free Cash Flow (ttm)-70.08M